Literature DB >> 35243703

Case of endoscopic bilateral stent-in-stent placement using long metallic stents for pancreatic cancer and plexus invasion.

Masanari Sekine1, Keita Matsumoto1, Hirosato Mashima1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35243703      PMCID: PMC9314804          DOI: 10.1111/den.14246

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   6.337


× No keyword cloud information.

BRIEF EXPLANATION

A 75‐year‐old man presented with obstructive jaundice due to pancreatic cancer (Fig. 1). He had a long malignant biliary obstruction consisting of two stenoses: one in the distal bile duct caused by pancreatic cancer and the other (type 2 according to the Bismuth classification) caused by plexus invasion along the gastroduodenal artery to the right hepatic artery. First, bilateral endoscopic drainage was performed using two plastic stents. However, their patency was short. We then attempted partial stent‐in‐stent (pSIS) placement using a long stent (Zilver635; Cook Medical Endoscopy, Winston‐Salem, NC, USA). Two guidewires were advanced into the left and anterior branch of the right hepatic duct. On fluoroscopic imaging, the first stent (diameter, 8 mm; length, 12 cm) was inserted into the left bile duct across the ampulla of Vater. Next, a contrast catheter was advanced with a guidewire passed through the stent cell. The second stent (diameter, 8 mm; length, 10 cm) was easily placed through the mesh from the anterior branch of the right hepatic duct to above the ampulla (Fig. 2, Video S1). Bilateral metallic stenting can be achieved by pSIS or side‐by‐side (SBS) methods. While technically challenging, the safety and efficacy of this approach has been demonstrated. , We selected pSIS because it showed superior technical feasibility or patency than SBS by referring to the meta‐analysis. , Most metallic stents used in pSIS are 6–8 cm in length. We occasionally experience cases of long malignant biliary obstruction, requiring three metallic stents: one for the distal bile duct and two for the hilar bile duct obstruction. In this case, two long metallic stents were sufficient. With this approach, cost reduction can be expected. A long metallic stent may be useful for pSIS placement in cases involving malignant biliary obstruction from the distal bile duct to the hilar bile duct.
Figure 1

(Upper left) Contrast‐enhanced computed tomography (CE‐CT) showing pancreatic head cancer (arrowheads). (Upper right) Magnetic resonance cholangiopancreatography showed a long malignant biliary obstruction from the distal bile duct (arrowheads, yellow) to the hilar bile duct (arrows) and pancreatic duct stenosis (arrowhead, red). (Lower left and right) CE‐CT showed wall thickening of the common bile duct (arrowheads) and a low‐density area around the right hepatic artery (arrows).

Figure 2

Partial stent‐in‐stent method for malignant biliary obstruction from the distal bile duct to the hilar bile duct. The length of each stent was determined by measuring from the intact intrahepatic bile duct to the duodenum or into the first stent.

Authors declare no conflict of interest for this article. (Upper left) Contrast‐enhanced computed tomography (CE‐CT) showing pancreatic head cancer (arrowheads). (Upper right) Magnetic resonance cholangiopancreatography showed a long malignant biliary obstruction from the distal bile duct (arrowheads, yellow) to the hilar bile duct (arrows) and pancreatic duct stenosis (arrowhead, red). (Lower left and right) CE‐CT showed wall thickening of the common bile duct (arrowheads) and a low‐density area around the right hepatic artery (arrows). Partial stent‐in‐stent method for malignant biliary obstruction from the distal bile duct to the hilar bile duct. The length of each stent was determined by measuring from the intact intrahepatic bile duct to the duodenum or into the first stent. Video S1 The long metallic stents were successfully placed by partial stent‐in‐stent for malignant biliary obstruction from the distal bile duct to the hilar bile duct due to pancreatic cancer and plexus invasion. Click here for additional data file.
  5 in total

1.  Risk factors for technical failure of endoscopic double self-expandable metallic stent placement by partial stent-in-stent method.

Authors:  Kazumichi Kawakubo; Hiroshi Kawakami; Yoshihide Toyokawa; Koichi Otani; Masaki Kuwatani; Yoko Abe; Shuhei Kawahata; Kimitoshi Kubo; Yoshimasa Kubota; Naoya Sakamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-10-12       Impact factor: 7.027

2.  Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video).

Authors:  Tae Hoon Lee; Tae Hyeon Kim; Jong Ho Moon; Sang Hyub Lee; Hyun Jong Choi; Young Hwangbo; Jong Jin Hyun; Jun-Ho Choi; Seok Jeong; Jong Hyeok Kim; Do Hyun Park; Joung-Ho Han; Sang-Heum Park
Journal:  Gastrointest Endosc       Date:  2017-05-04       Impact factor: 9.427

3.  Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture.

Authors:  Tae Hoon Lee; Jong Ho Moon; Jun-Ho Choi; Sang Hyub Lee; Yun Nah Lee; Woo Hyun Paik; Dong Kee Jang; Byeong Wook Cho; Jae Kook Yang; Young Hwangbo; Sang-Heum Park
Journal:  Gastrointest Endosc       Date:  2019-03-21       Impact factor: 9.427

4.  Endoscopic Bilateral Stent-in-Stent Versus Stent-by-Stent Deployment in Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review.

Authors:  Sung Ryul Shim; Tae Hoon Lee; Jae Kook Yang; Jae Heon Kim; Yun Nah Lee; Sang-Woo Cha; Jong Ho Moon; Young Deok Cho; Sang-Heum Park
Journal:  Dig Dis Sci       Date:  2021-02-24       Impact factor: 3.199

5.  Endoscopic retrograde cholangiopancreatography drainage for palliation of malignant hilar biliary obstruction - stent-in-stent or side-by-side? A systematic review and meta-analysis.

Authors:  Gabriel Mayo Vieira de Souza; Igor Braga Ribeiro; Mateus Pereira Funari; Diogo Turiani Hourneaux de Moura; Maria Vitória Cury Vieira Scatimburgo; João Remí de Freitas Júnior; Sergio A Sánchez-Luna; Renato Baracat; Eduardo Turiani Hourneaux de Moura; Wanderley Marques Bernardo; Eduardo Guimarães Hourneaux de Moura
Journal:  World J Hepatol       Date:  2021-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.